Literature DB >> 15146100

Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty.

A Olivares1, D Söderlund, C Castro-Fernández, T Zariñán, Elena Zambrano, J P Méndez, A Ulloa-Aguirre.   

Abstract

Follicle-stimulating hormone is synthesized and secreted as a mixture of heterogeneous isoforms that differ from each other in carbohydrate structure, biological potency, and plasma half-life. The relative abundance of the FSH isoforms will depend on the endocrine status of the donor at the time of sample collection. In the present study, we attempted to define the impact of the changing endocrine milieu characteristic of male puberty on the charge heterogeneity and plasma half-life of the serum FSH isoforms released under endogenous and exogenous GnRH drives, and examined whether such a varying hormone milieu modifies the capability of the circulating hormone to trigger intracellular signal transduction at the human FSH receptor level. Forty healthy male subjects at Tanner stages (Ts) 1 to 5 were sampled at 10 min intervals for 10 h. Serum from successive samples collected across 2-4 h intervals containing FSH released under basal, low-dose (10 microg), and high-dose (90 microg) exogenous GnRH-stimulated conditions was subjected to preparative chromatofocusing and tested for bioactivity employing a homologous cell in vitro bioassay system. Deconvolution analysis was applied to estimate the apparent endogenous FSH plasma half-life in samples obtained after administration of low-dose exogenous GnRH. Under all conditions studied, serum FSH charge isoforms were distributed along a pH range of 7.0 to less than 3.0. Comparisons across the different Tanner stages revealed a significant and selective increase in the ratio of FSH isoforms with elution pH values <4.50 relative to those with values >/=4.50 at Ts-2. At Ts-3, this ratio returned to that present at Ts-1, to decline thereafter during the ensuing pubertal stages. Serum bioactive FSH concentrations progressively increased (from 3.72 +/- 1.3 to 16.2 +/- 5.3 IU/L) throughout puberty, and in all conditions bioactive FSH concentrations exceeded those detected by a specific radioimmunoassay. The biological to immunological (B:I) FSH ratio at baseline was significantly (p < 0.05) lower at Ts-1 and Ts-2 (1.33 +/- 0.30 and 1.62 +/- 0.34, respectively) than at more advanced stages of pubertal development (2.28 +/- 0.20, 2.96 +/- 0.38, and 2.77 +/- 0.63 at Ts-3-, 4-, and -5, respectively) Similar differences were detected in samples containing FSH molecules released after low- and high-dose GnRH administration. The apparent endogenous FSH half-life of the deconvolved GnRH-induced FSH pulses was similar in the five study groups. These results demonstrate that the transition from infancy to sexual maturity in men is accompanied by qualitative changes in the circulating FSH isoform mixture. Although the changes in FSH glycosylation occurring throughout puberty are not of sufficient magnitude to alter the survival of the gonadotropin in circulation, they allow preferential secretion of bioactive FSH. The enrichment of the circulating mix of FSH isoforms with highly bioactive variants throughout spontaneous puberty may potentially favor the development of spermatogenesis and acquisition of reproductive competence. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146100     DOI: 10.1385/ENDO:23:2-3:189

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  56 in total

1.  Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone.

Authors:  A Ulloa-Aguirre; A Cravioto; P Damián-Matsumura; M Jiménez; E Zambrano; V Díaz-Sánchez
Journal:  Hum Reprod       Date:  1992-01       Impact factor: 6.918

2.  Carbohydrate-dependent epitope mapping of human thyrotropin.

Authors:  M J Papandreou; I Sergi; M Benkirane; C Ronin
Journal:  Mol Cell Endocrinol       Date:  1990-10-01       Impact factor: 4.102

3.  Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants.

Authors:  E Zambrano; T Zariñán; A Olivares; J Barrios-de-Tomasi; A Ulloa-Aguirre
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

4.  Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone.

Authors:  E Zambrano; J Barrios-de-Tomasi; M Cárdenas; A Ulloa-Aguirre
Journal:  Mol Hum Reprod       Date:  1996-08       Impact factor: 4.025

5.  Signaling between the pituitary gland and the testes: inverse relationship between serum FSH and inhibin B concentrations in boys in early puberty.

Authors:  T Raivio; S Saukkonen; J Jääskeläinen; J Komulainen; L Dunkel
Journal:  Eur J Endocrinol       Date:  2000-02       Impact factor: 6.664

Review 6.  Role of glycosylation in function of follicle-stimulating hormone.

Authors:  A Ulloa-Aguirre; C Timossi; P Damián-Matsumura; J A Dias
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

7.  Oestrogens regulate pituitary alpha2,3-sialyltransferase messenger ribonucleic acid levels in the female rat.

Authors:  P Damián-Matsumura; V Zaga; A Maldonado; C Sánchez-Hernández; C Timossi; A Ulloa-Aguirre
Journal:  J Mol Endocrinol       Date:  1999-10       Impact factor: 5.098

8.  17 beta-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause.

Authors:  L Wide; T Naessén
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

9.  Serum bioactive luteinizing and follicle-stimulating hormone concentrations in girls increase during puberty.

Authors:  J Z Kasa-Vubu; V Padmanabhan; G B Kletter; M B Brown; E O Reiter; P C Sizonenko; I Z Beitins
Journal:  Pediatr Res       Date:  1993-12       Impact factor: 3.756

10.  Metabolic clearance of human follicle-stimulating hormone assessed by radioimmunoassay, immunoradiometric assay, and in vitro Sertoli cell bioassay.

Authors:  R J Urban; V Padmanabhan; I Beitins; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

View more
  1 in total

1.  In vitro biological-to-immunological ratio of serum gonadotropins throughout male puberty in children with insulin-dependent diabetes mellitus.

Authors:  Elisa Nishimura; Daniela Söderlund; Cecilia Castro-Fernández; Teresa Zariñán; Juan Pablo Méndez; Alfredo Ulloa-Aguirre
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.